BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9029387)

  • 1. Risk of recurrence of craniospinal anomalies.
    Papp C; Adám Z; Tóth-Pál E; Török O; Váradi V; Papp Z
    J Matern Fetal Med; 1997; 6(1):53-7. PubMed ID: 9029387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic aspects of "uncomplicated" hydrocephalus and its relationship to neural tube defect.
    Laurence KM
    Z Kinderchir; 1984 Dec; 39 Suppl 2():96-9. PubMed ID: 6524107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe fetal hydrocephalus with and without neural tube defect: a comparative study.
    Schlatter D; Sanseverino MT; Schmitt JM; Fritsch A; Kessler RG; Barrios PM; Palma-Dias RS; Magalhães JA
    Fetal Diagn Ther; 2008; 23(1):23-9. PubMed ID: 17934294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hydrocephalus. Clinical significance of associated anomalies and genetic counseling: a pathological approach.
    Roume J; Larroche JC; Razavi-Encha F; Gonzales M; Migne G; Mulliez N
    Genet Couns; 1990; 1(3-4):185-96. PubMed ID: 2098043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic counseling and prenatal diagnosis in families with neural tube defects].
    Mikiel-Kostyra K
    Probl Med Wieku Rozwoj; 1983; 12():244-62. PubMed ID: 6674977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancies of mothers with a neural tube defect child: outcomes and recurrence risks.
    Swerts A; Evers-Kiebooms G; Van den Berghe H
    J Genet Hum; 1987 Dec; 35(5):339-49. PubMed ID: 3437264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recurrence risk for neural tube defects in the United States: a collaborative study.
    Cowchock S; Ainbender E; Prescott G; Crandall B; Lau L; Heller R; Muir WA; Kloza E; Feigelson M; Mennuti M; Cederquist L
    Am J Med Genet; 1980; 5(3):309-14. PubMed ID: 7405962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of fetuses with a pre-termination diagnosis of neural tube defect or hydrocephalus.
    Donnai D; Farndon PA
    Z Kinderchir; 1985 Dec; 40 Suppl 1():51-2. PubMed ID: 4090756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Twenty years of nationwide clinico-epidemiological survey of fetal hydrocephalus in Japan].
    Moritake K; Yamasaki M; Mori K; Kikuchi H
    No Shinkei Geka; 2008 Jan; 36(1):7-24. PubMed ID: 18232318
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity and recurrence risk for congenital hydrocephalus (ventriculomegaly): a prospective study.
    Váradi V; Tóth Z; Török O; Papp Z
    Am J Med Genet; 1988 Feb; 29(2):305-10. PubMed ID: 3354602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empiric recurrence risk for neural tube defects (NTD) in Krakow region.
    Pietrzyk JJ
    Acta Anthropogenet; 1983; 7(4):367-72. PubMed ID: 6680315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent neural tube defects.
    Goh SL; Tan JV; Kwek KY; Yeo GS
    Singapore Med J; 2006 Aug; 47(8):728-9. PubMed ID: 16865218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated and ventriculomegaly-associated cases of spina bifida in genetic counseling: focus on fetal pathology.
    Joó JG; Csaba Á; Szigeti Z; Rigó J
    Pathol Res Pract; 2013 Jul; 209(7):409-12. PubMed ID: 23706941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural tube malformations: complex segregation analysis and recurrence risk.
    Pietrzyk JJ
    Am J Med Genet; 1980; 7(3):293-300. PubMed ID: 7008595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal hydrocephalus: sonographic detection and clinical significance of associated anomalies.
    Nyberg DA; Mack LA; Hirsch J; Pagon RO; Shepard TH
    Radiology; 1987 Apr; 163(1):187-91. PubMed ID: 3547493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of neural tube defects among first-, second-, and third-degree relatives of probands: results of a United States study.
    Toriello HV; Higgins JV
    Am J Med Genet; 1983 Aug; 15(4):601-6. PubMed ID: 6614048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief report pregnancy outcome in women assigned an ICD-9/ICD-9-CM 655.0 code "central nervous system malformation in fetus affecting management of pregnancy": can these codes aid in surveillance for central nervous system defects?
    Evans JA
    Birth Defects Res A Clin Mol Teratol; 2014 Nov; 100(11):848-51. PubMed ID: 25073455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of a neural tube defect recurrence-prevention program.
    Grosse SD; Ouyang L; Collins JS; Green D; Dean JH; Stevenson RE
    Am J Prev Med; 2008 Dec; 35(6):572-7. PubMed ID: 18845415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.